JP2020532538A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532538A5 JP2020532538A5 JP2020512506A JP2020512506A JP2020532538A5 JP 2020532538 A5 JP2020532538 A5 JP 2020532538A5 JP 2020512506 A JP2020512506 A JP 2020512506A JP 2020512506 A JP2020512506 A JP 2020512506A JP 2020532538 A5 JP2020532538 A5 JP 2020532538A5
- Authority
- JP
- Japan
- Prior art keywords
- equation
- aliphatic
- aryl
- heteroaliphatic
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCI(C(*C(*(C)C)=*1)=C)*1=C(C)C(c1ccc(C(C)C=C)cc1)=**=C(C)*C Chemical compound CCI(C(*C(*(C)C)=*1)=C)*1=C(C)C(c1ccc(C(C)C=C)cc1)=**=C(C)*C 0.000 description 24
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZNKKYYNWFKHNHZ-UHFFFAOYSA-N CC1C=CC=CC1 Chemical compound CC1C=CC=CC1 ZNKKYYNWFKHNHZ-UHFFFAOYSA-N 0.000 description 1
- BRWRRWXQMCPPRZ-ROLXFIACSA-N C[C@@H]1C(CN)C1 Chemical compound C[C@@H]1C(CN)C1 BRWRRWXQMCPPRZ-ROLXFIACSA-N 0.000 description 1
- ZNKKYYNWFKHNHZ-ZETCQYMHSA-N C[C@H]1C=CC=CC1 Chemical compound C[C@H]1C=CC=CC1 ZNKKYYNWFKHNHZ-ZETCQYMHSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Cc1ccccc1 Chemical compound Cc1ccccc1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023160601A JP2024001064A (ja) | 2017-09-01 | 2023-09-25 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
| JP2025187943A JP2026041735A (ja) | 2017-09-01 | 2025-11-07 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762553714P | 2017-09-01 | 2017-09-01 | |
| US62/553,714 | 2017-09-01 | ||
| PCT/US2018/049163 WO2019046761A1 (en) | 2017-09-01 | 2018-08-31 | THERAPEUTIC METAL COMPLEXES AND LIGANDS, METHODS OF MAKING AND USING SAME |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023160601A Division JP2024001064A (ja) | 2017-09-01 | 2023-09-25 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020532538A JP2020532538A (ja) | 2020-11-12 |
| JP2020532538A5 true JP2020532538A5 (enExample) | 2021-10-07 |
| JP7894113B2 JP7894113B2 (ja) | 2026-07-23 |
Family
ID=63684510
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512506A Active JP7894113B2 (ja) | 2017-09-01 | 2018-08-31 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
| JP2023160601A Pending JP2024001064A (ja) | 2017-09-01 | 2023-09-25 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
| JP2025187943A Pending JP2026041735A (ja) | 2017-09-01 | 2025-11-07 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023160601A Pending JP2024001064A (ja) | 2017-09-01 | 2023-09-25 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
| JP2025187943A Pending JP2026041735A (ja) | 2017-09-01 | 2025-11-07 | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11596651B2 (enExample) |
| EP (1) | EP3676271A1 (enExample) |
| JP (3) | JP7894113B2 (enExample) |
| CN (1) | CN111278835A (enExample) |
| AU (1) | AU2018325283B2 (enExample) |
| CA (1) | CA3074258A1 (enExample) |
| IL (1) | IL272895B2 (enExample) |
| WO (1) | WO2019046761A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7894113B2 (ja) * | 2017-09-01 | 2026-07-23 | オレゴン ステイト ユニバーシティー | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
| EP4003361A1 (en) * | 2019-07-25 | 2022-06-01 | ALS Therapy Development Institute | Cuptsm for the treatment of neurodegenerative disorders |
| CN116234800A (zh) * | 2020-08-26 | 2023-06-06 | Als治疗发展学会 | 用于治疗神经退行性病症的铜络合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7403524A (en) | 1959-09-15 | 1974-05-27 | Pharmaceutical compsn. - contg. alpha-dithiosemicarbazone active against trichomonas vaginalis | |
| US4107210A (en) | 1976-09-07 | 1978-08-15 | The Dow Chemical Company | Synthesis of alpha-diketones |
| CA2166676C (en) * | 1995-01-09 | 2007-05-01 | Yasuhisa Fujibayashi | Diagnostic agent for hypoxia or mitochondrial dysfunction comprising radioactive copper complex of dithiosemicarbazone derivative or diamine diol schiff base derivative |
| GB0617299D0 (en) * | 2006-09-01 | 2006-10-11 | Isis Innovation | Compounds for imaging and therapy |
| ES2650720T3 (es) | 2006-11-20 | 2018-01-22 | The University Of Melbourne | Agentes de suministro de metales y usos terapéuticos de los mismos |
| WO2010066010A1 (en) | 2008-12-12 | 2010-06-17 | The University Of Melbourne | Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| ES2778038T3 (es) * | 2013-11-11 | 2020-08-07 | Collaborative Medicinal Development Llc | Complejos metálicos y métodos de tratamiento |
| WO2017070752A1 (en) * | 2015-10-29 | 2017-05-04 | The University Of Queensland | Imaging agents |
| WO2017214546A1 (en) * | 2016-06-10 | 2017-12-14 | University Of Louisville Research Foundation, Inc. | Compounds, related compositions, catalysts, electrochemical cells, fuel cells, their preparation and their uses |
| WO2018204564A1 (en) * | 2017-05-04 | 2018-11-08 | University Of Louisville Research Foundation, Inc. | Thiosemicarbazone derivatives as anti-cancer agents |
| JP7894113B2 (ja) * | 2017-09-01 | 2026-07-23 | オレゴン ステイト ユニバーシティー | 治療用金属錯体およびリガンドならびにその作成および使用の方法 |
-
2018
- 2018-08-31 JP JP2020512506A patent/JP7894113B2/ja active Active
- 2018-08-31 CN CN201880065301.9A patent/CN111278835A/zh active Pending
- 2018-08-31 AU AU2018325283A patent/AU2018325283B2/en active Active
- 2018-08-31 EP EP18778677.7A patent/EP3676271A1/en active Pending
- 2018-08-31 WO PCT/US2018/049163 patent/WO2019046761A1/en not_active Ceased
- 2018-08-31 CA CA3074258A patent/CA3074258A1/en active Pending
- 2018-08-31 IL IL272895A patent/IL272895B2/en unknown
-
2020
- 2020-02-26 US US16/802,410 patent/US11596651B2/en active Active
-
2023
- 2023-01-27 US US18/102,474 patent/US12403159B2/en active Active
- 2023-09-25 JP JP2023160601A patent/JP2024001064A/ja active Pending
-
2025
- 2025-11-07 JP JP2025187943A patent/JP2026041735A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2833766B2 (ja) | アミノポリカルボン酸およびその誘導体 | |
| JP7449864B2 (ja) | エバンスブルー誘導体の化学結合体ならびに前立腺癌を標的とするための放射線療法および造影剤としてのその使用 | |
| EP0955044B1 (en) | Method of inhibiting bacterial or fungal growth using a complexing agent | |
| CN106660943B (zh) | 用于psma靶向的成像和放射疗法的金属/放射性金属标记的psma抑制物 | |
| US8623322B2 (en) | Non-invasive diagnostic agents and methods of diagnosing infectious disease | |
| JP2020528889A5 (enExample) | ||
| JP2010523599A5 (enExample) | ||
| JP2020530007A5 (enExample) | ||
| KR20110013411A (ko) | (ｆ-19)-표지된 ｌ-글루탐산 및 ｌ-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법 | |
| JP2010511687A5 (enExample) | ||
| JP2024510267A5 (enExample) | ||
| JP2012504131A5 (enExample) | ||
| Santos et al. | Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: Synthesis, complexation with Fe (III), Al (III) and Ga (III) and in vivo evaluation with 67Ga | |
| JPH09501919A (ja) | ホスホネート部分と非ホスホネート部分との両者を有するｍｒｉ用のポリアミノ常磁性キレート | |
| JP2016514151A (ja) | ガドフォスベセット三ナトリウム一水和物の製造方法 | |
| JP2024001064A (ja) | 治療用金属錯体およびリガンドならびにその作成および使用の方法 | |
| EP3229848B1 (en) | Targeted contrast agents comprising a hydrazide functional group | |
| US20150291538A1 (en) | Macrocyclic Compositions And Metal Complexes For Bioimaging And Biomedical Applications | |
| KR101861025B1 (ko) | 영상화 제제로서의 ｎ-알콕시아미드 접합체 | |
| JP5322651B2 (ja) | シンチグラフィー法 | |
| KR100778888B1 (ko) | 베타아밀로이드 펩타이드 플라크의 영상화를 위한벤질리덴아닐린 계열의 유도체 및 그의 방사성 동위원소표지화합물 | |
| EP4015509A1 (en) | Organometallic compounds and their use as multimodal contrasting media for imaging diagnosis |